Skip to main content

and
  1. Article

    Open Access

    Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer

    Although docetaxel-based chemohormonal therapy (CHT) is one of the standard treatments for castration-resistant prostate cancer (CRPC), pertinent biomarkers and precise mechanisms involved in the resistance fo...

    Yoshinori Matsuda, Shintaro Narita, Taketoshi Nara, Huang Mingguo in BMC Cancer (2020)

  2. Article

    Open Access

    Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis

    The insulin-like growth factor-1 (IGF-1) plays an important role in growth of prostate cancer (PCa) cells and facilitating the development and progression of PCa. This study aimed to evaluate the association o...

    Norihiko Tsuchiya, Shintaro Narita, Takamitsu Inoue, Mitsuru Saito in BMC Cancer (2013)

  3. Article

    Open Access

    Post-transplant lymphoproliferative disorder involving the ovary as an initial manifestation: a case report

    Because the normal ovary is assumed to be devoid of lymphoid tissue, it is unusual for it to be an initial manifestation of malignant lymphoma. This case is the first report, to our knowledge, of post-transpla...

    Takamitsu Inoue, Shigeru Satoh, Mitsuru Saito in Journal of Medical Case Reports (2010)

  4. Article

    Open Access

    A genetic polymorphism of the osteoprotegerin gene is associated with an increased risk of advanced prostate cancer

    The purpose of this study was to evaluate the role of osteoprotegerin gene (OPG) polymorphisms as genetic modifiers in the etiology of prostate cancer (PCa) and disease progression.

    Naofumi Narita, Takeshi Yuasa, Norihiko Tsuchiya, Teruaki Kumazawa in BMC Cancer (2008)